Shandong Weigao repurchases shares, boosting treasury holdings

Shandong Weigao Group Medical Polymer Company Limited announced a share repurchase on November 26, 2025. The company repurchased 160,000 H-shares on the Exchange at prices ranging from HKD 5.62 to HKD 5.65, with an aggregate price paid of HKD 901,200. This repurchase represents 0.0036% of its existing issued shares (excluding treasury shares) before the event.

As a result of this transaction, the number of issued shares (excluding treasury shares) decreased from 4,495,796,324 to 4,495,636,324. Concurrently, the number of treasury shares increased from 26,536,000 to 26,696,000. The total number of issued shares remains unchanged at 4,522,332,324.

The repurchase was made under a mandate granted on May 27, 2025, which authorized the repurchase of up to 451,560,392 shares. To date, the company has repurchased 20,047,600 shares, representing 4.4396% of the issued shares (excluding treasury shares) as of the mandate date. A moratorium period for any new share issues or treasury share sales after this repurchase extends until December 25, 2025.